Clinical trials
Active, not recruiting Multiple Myeloma trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 4 |
| Celgene | 2 |
| Stichting European Myeloma Network | 2 |
| Bristol-Myers Squibb | 1 |
| European Myeloma Network B.V. | 1 |
| Genentech, Inc. | 1 |
| Ida Bruun Kristensen | 1 |
| Janssen Research & Development, LLC | 1 |
| Pfizer | 1 |
| Raija Silvennoinen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 16 |
| Hematologic Diseases | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.